This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 29/5/761    most recent ATVBAHA.108.183384v1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Villa-Bellosta, R. Articles by Sorribas, V. Search for Related Content PubMed PubMed Citation Articles by Villa-Bellosta, R. Articles by Sorribas, V. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CALCIUM BIS(DIHYDROGEN PHOSPHATE) CALCIUM HYDROGEN PHOSPHATE

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2009;29:761.)
© 2009 American Heart Association, Inc.

Cell Biology/Signaling

Phosphonoformic Acid Prevents Vascular Smooth Muscle Cell Calcification by Inhibiting Calcium-Phosphate Deposition

Ricardo Villa-Bellosta; Víctor Sorribas

From the Laboratory of Molecular Toxicology, University of Zaragoza, Spain.

Correspondence to Víctor Sorribas, Laboratory of Molecular Toxicology, University of Zaragoza, Veterinary Faculty, Calle Miguel Servet 177, 50013 Zaragoza, Spain. E-mail sorribas{at}unizar.es

Objective— The role of inorganic phosphate in the pathogenesis of vascular calcification (VC) has been studied extensively in recent years. Phosphonoformic acid (PFA), an inhibitor of type II Pi transporters, has been traditionally used to study the involvement of Pi transport in VC, because PFA also prevents calcium deposition in vitro. However, aortic vascular smooth muscle cells (VSMCs) only express PFA-resistant, type III transporters (Pit-1 and Pit-2). Therefore, in this article we have studied the mechanism of VC prevention by PFA.

Methods and Results— Radiotracer Pi uptake in rat VSMCs was not inhibited at the concentrations at which PFA prevents calcification. Alternative mechanisms whereby PFA could prevent calcification, such as cytotoxicity or phosphodiesterase inhibition, have also been excluded. The progression of calcification also took place in fixed cells. The kinetics of VC prevention by PFA, pyrophosphate, phosphonoacetate, and bisphosphonates was similar in live and fixed cells, showing mean effective concentrations in the micromolar range.

Conclusions— PFA mainly prevents VC through a physicochemical mechanism that is independent of any cellular metabolic activity, including Pi transport. Conversely, PFA seems to act similarly to its chemical analogues, inorganic pyrophosphate, and bisphosphonates, as suggested decades ago.

Phosphonoformate prevents calcification in vascular smooth muscle cells but does not inhibit Pi transport. Cytotoxicity and phosphodiesterase inhibition by phosphonoformate have also been discarded. Phosphonoformate prevents calcification in fixed cells, which suggests that the mechanism is independent of any cellular activity. We conclude that phosphonoformate acts as a pyrophosphate analogue.

Key Words: phosphonoformic acid • bisphosphonate • vascular calcification • phosphate transport • Pit-1

This article has been cited by other articles:

				R. Villa-Bellosta and V. Sorribas Different effects of arsenate and phosphonoformate on Pi transport adaptation in opossum kidney cells Am J Physiol Cell Physiol, January 1, 2009; 297(3): C516 - C525. [Abstract] [Full Text] [PDF]